These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34143301)

  • 1. Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.
    Shroff R
    Pediatr Nephrol; 2021 Aug; 36(8):2537-2544. PubMed ID: 34143301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.
    Bansal N
    Semin Nephrol; 2017 Mar; 37(2):120-131. PubMed ID: 28410646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors in children on dialysis: an update.
    Querfeld U; Schaefer F
    Pediatr Nephrol; 2020 Jan; 35(1):41-57. PubMed ID: 30382333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
    Levin A
    Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease.
    Karangizi AHK; Chanouzas D; Fenton A; Moss P; Cockwell P; Ferro CJ; Harper L
    QJM; 2020 Apr; 113(4):253-257. PubMed ID: 31613364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Hypothyroidism, Kidney, and Heart from Normal to Uremic Milieu.
    Spahia N; Rroji M; Barbullushi M; Spasovski G
    Metab Syndr Relat Disord; 2023 Oct; 21(8):415-425. PubMed ID: 37433213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Risk Prediction in Chronic Kidney Disease.
    Li X; Lindholm B
    Am J Nephrol; 2022; 53(10):730-739. PubMed ID: 36481730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in children with chronic kidney disease.
    Mitsnefes MM
    J Am Soc Nephrol; 2012 Apr; 23(4):578-85. PubMed ID: 22383696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Mineral and Bone Disorder of Chronic Kidney Disease and Cardiovascular Disease.
    Kusumi K; Kremsdorf R; Kakajiwala A; Mahan JD
    Adv Chronic Kidney Dis; 2022 May; 29(3):275-282. PubMed ID: 36084974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?
    Shroff R; Quinlan C; Mitsnefes M
    Pediatr Nephrol; 2011 Jun; 26(6):853-65. PubMed ID: 21080003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia in patients with chronic kidney disease: etiology and management.
    Dušejovská M; Vecka M; Rychlík I; Žák A
    Vnitr Lek; 2020; 66(5):275-281. PubMed ID: 32942864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mechanisms involved in the development of cardiovascular disease in chronic kidney disease.
    Figuer A; Alique M; Valera G; Serroukh N; Ceprían N; de Sequera P; Morales E; Carracedo J; Ramírez R; Bodega G
    Nefrologia (Engl Ed); 2023; 43(1):63-80. PubMed ID: 37268501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease.
    Khouzam N; Wesseling-Perry K
    Pediatr Nephrol; 2019 Jan; 34(1):1-10. PubMed ID: 28939921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of chronic kidney disease in cardiovascular disease: are we different from others?
    Iseki K
    Clin Exp Nephrol; 2011 Aug; 15(4):450-5. PubMed ID: 21465119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
    Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
    Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients.
    Lascasas JMSS; Fonseca I; Malheiro J; Santos S; Campos A; Castro A; Moreira C; Correia S; Beirão I; Lobato L; Cabrita A
    J Bras Nefrol; 2019; 41(1):29-37. PubMed ID: 31063177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and Cardiovascular Disease Outcomes in Chronic Kidney Disease: Reaffirmation vs. Repudiation.
    Obialo CI; Ofili EO; Norris KC
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30518032
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.